Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APRE | BMY | AMGN | GILD | REGN |
| Company | Aprea Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.95 | 49.89 | 337.03 | 84.39 | 1,149.66 |
| High | 2.95 | 50.04 | 338.70 | 84.65 | 1,165.85 |
| Low | 2.95 | 49.11 | 334.61 | 83.57 | 1,148.13 |
| Last | 2.95 | 49.33 | 336.58 | 84.48 | 1,160.73 |
| Change | +0.09 | -0.41 | +3.66 | +0.59 | +21.92 |
| % Change | +3.03% | -0.82% | +1.10% | +0.70% | +1.92% |
| Volume | 501 | 2,264,441 | 481,551 | 2,525,659 | 261,536 |
| 20-Day Average Volume | 6,760 | 8,277,336 | 1,702,433 | 6,374,733 | 403,247 |
| Previous Close | 2.86 | 49.74 | 332.92 | 83.89 | 1,138.81 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.32 | 49.10 | 329.61 | 80.09 | 1,166.10 |
| 20-Day Raw Stochastic | 8.66% | 63.00% | 87.00% | 92.75% | 49.62% |
| 20-Day Relative Strength | 37.40% | 55.55% | 58.00% | 72.44% | 55.32% |
| Weighted Alpha | -44.31 | -10.45 | +27.33 | +18.82 | +43.11 |
| Today's Opinion | 100% Sell | 72% Buy | 96% Buy | 88% Buy | 80% Buy |
| Previous Opinion | 100% Sell | 72% Buy | 88% Buy | 88% Buy | 80% Buy |
| Last Month's Opinion | 88% Sell | 40% Buy | 88% Buy | 56% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -13.84% since 09/12/24 | +2.24% since 09/12/24 | +1.92% since 09/12/24 | +1.25% since 09/12/24 | -0.22% since 09/12/24 |
| Low | 2.86 on 09/18/24 | 48.20 on 09/13/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 1,134.59 on 09/17/24 |
| High | 3.32 on 09/13/24 | 50.41 on 09/17/24 | 339.00 on 09/18/24 | 84.61 on 09/19/24 | 1,170.58 on 09/13/24 |
| 1-Month | |||||
| %Chg | -22.15% since 08/19/24 | +0.04% since 08/19/24 | +2.57% since 08/19/24 | +13.09% since 08/19/24 | -2.93% since 08/19/24 |
| Low | 2.86 on 09/18/24 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 1,113.24 on 09/11/24 |
| High | 3.86 on 08/22/24 | 50.75 on 09/04/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
| 3-Month | |||||
| %Chg | -27.60% since 06/18/24 | +20.85% since 06/18/24 | +9.94% since 06/18/24 | +33.33% since 06/18/24 | +11.81% since 06/18/24 |
| Low | 2.86 on 09/18/24 | 39.35 on 07/05/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 1,011.67 on 07/03/24 |
| High | 4.34 on 06/25/24 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
| 6-Month | |||||
| %Chg | -56.28% since 03/19/24 | -4.79% since 03/19/24 | +23.80% since 03/19/24 | +14.70% since 03/19/24 | +20.57% since 03/19/24 |
| Low | 2.86 on 09/18/24 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 875.22 on 04/26/24 |
| High | 6.80 on 03/28/24 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 15,530 | 100,827,960 | 178,589,936 | 104,514,608 | 125,480,912 |
| Shares Outstanding, K | 5,430 | 2,027,100 | 536,435 | 1,245,853 | 110,186 |
| Annual Sales | 580,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -14,290,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 560,000 | 12,201,000,000 | 8,388,000,000 | 6,954,000,000 | 3,547,100,000 |
| Last Quarter Net Income | -3,470,000 | 1,680,000,000 | 746,000,000 | 1,614,000,000 | 1,432,300,000 |
| 60-Month Beta | 1.04 | 0.46 | 0.61 | 0.18 | 0.12 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.58 on 08/12/24 | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 11.56 on 08/01/24 |
| Latest Earnings Date | 08/08/24 | 10/31/24 | 10/29/24 | 11/05/24 | 11/07/24 |
| Most Recent Dividend | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 36.12 | 17.89 | 17.67 | 29.85 |